We are live on
!
Find out more
TCM
Tang Capital Management Portfolio holdings
AUM
$1.97B
1-Year Est. Return
125.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.32%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$282M
AUM Growth
+$5.08M
(+1.8%)
Cap. Flow
+$6.26M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
+$6.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Heron Therapeutics
HRTX
|
+$162K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
HA
SGAM
CCA
FWTB
NIM
RMCM
FC
SC
Tang Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Tang Capital Management held 5 positions worth $282M, up 1.8% from $277M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 0%. Tang Capital Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tang Capital Management added most to Ignyta, Inc. in Q2 2017, an estimated $6.42M increase.
- Tang Capital Management's biggest Q2 2017 reduction was Heron Therapeutics, cutting an estimated $162K.
- Tang Capital Management's ten largest holdings make up 100% of its $282M portfolio in Q2 2017.
- Tang Capital Management opened 0 new positions and closed 0 in Q2 2017.
- Tang Capital Management's portfolio value rose 1.8% quarter-over-quarter to $282M.
Based on Tang Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.